Histamine H1 receptor down-regulation mediated by M3 muscarinic acetylcholine receptor subtype.
Heterologous down-regulation of histamine H(1) receptor (H1R) mediated by muscarinic acetylcholine receptor subtype was investigated using five kinds of Chinese hamster ovary (CHO) cells stably co-expressing the human H1R and one of the five (M(1) - M(5)) muscarinic acetylcholine receptors, CHO-H1/M1, CHO-H1/M2, CHO-H1/M3, CHO-H1/M4, and CHO-H1/M5 cells. Among the CHO-H1/M1, CHO-H1/M3, and CHO-H1/M5 cells, carbachol treatment of the CHO-H1/M3 cells time-dependently led to remarkable down-regulation of the H1R to 60% of the control level. In contrast, stimulation of CHO-H1/M1 cells by carbachol induced negligible effect on the down-regulation. Stimulation of CHO-H1/M5 cells by carbachol induced significant but only small H1R down-regulation. M(2) and M(4) muscarinic receptors showed negligible effect on the down-regulation. H1R-mediated accumulation of inositol phosphates in CHO-H1/M3 cells with long-term expose to carbachol was decreased to 60% compared with non-treated cells. Heterologous phosphorylation of H1R was induced by the stimulation of each muscarinic receptor. H1R was phosphorylated by about twofold from the basal level through five subtypes of muscarinic receptor. The M(3) muscarinic receptor-mediated phosphorylation of H1R was reversed by the inhibition of protein kinase C. In the present study we demonstrated that the M(3) muscarinic acetylcholine receptor mediated remarkable down-regulation of the H1R with decreased receptor signaling.
Miyoshi
Katsuhiro
K
Department of Pharmacology, Faculty of Pharmaceutical Sciences, The University of Tokushima, Tokushima 770-8505, Japan.
Kawakami
Nozomi
N
Wakayama
Yousuke
Y
Izumi
Norimasa
N
Horio
Shuhei
S
Fukui
Hiroyuki
H
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D016466:CHO Cells; D002217:Carbachol / Q000494:pharmacology; D002227:Carbazoles / Q000494:pharmacology; D018679:Cholinergic Agonists / Q000494:pharmacology; D006224:Cricetinae; D003412:Cricetulus; D015536:Down-Regulation; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D007295:Inositol Phosphates / Q000096:biosynthesis; D018727:Muscarinic Antagonists / Q000494:pharmacology; D010766:Phosphorylation; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011738:Pyrilamine / Q000378:metabolism; D011869:Radioligand Assay; D043587:Receptor, Muscarinic M3 / Q000235:genetics / Q000378:metabolism*; D011969:Receptors, Histamine H1 / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D013997:Time Factors
D002227:Carbazoles; D018679:Cholinergic Agonists; D006634:Histamine H1 Antagonists; D007211:Indoles; D007295:Inositol Phosphates; D018727:Muscarinic Antagonists; D043587:Receptor, Muscarinic M3; D011969:Receptors, Histamine H1; C073601:KT 5823; D001285:Atropine; D002217:Carbachol; D011493:Protein Kinase C; D011738:Pyrilamine; C064758:Ro 31-8220